Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension

Drugs. 1977 Sep;14(3):163-97. doi: 10.2165/00003495-197714030-00002.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Review

MeSH terms

  • Animals
  • Benzothiadiazines
  • Blood Pressure / drug effects
  • Clinical Trials as Topic
  • Diuretics
  • Drug Eruptions / etiology
  • Drug Therapy, Combination
  • Heart Rate / drug effects
  • Humans
  • Hydralazine / adverse effects
  • Hydralazine / therapeutic use
  • Hypertension / drug therapy*
  • Hypertension / physiopathology
  • Kidney / drug effects
  • Kidney Diseases / drug therapy
  • Kinetics
  • Methyldopa / adverse effects
  • Methyldopa / therapeutic use
  • Prazosin / adverse effects
  • Prazosin / metabolism
  • Prazosin / pharmacology*
  • Prazosin / therapeutic use
  • Quinazolines / pharmacology*
  • Renin / blood
  • Sodium Chloride Symporter Inhibitors / therapeutic use
  • Time Factors

Substances

  • Benzothiadiazines
  • Diuretics
  • Quinazolines
  • Sodium Chloride Symporter Inhibitors
  • Hydralazine
  • Methyldopa
  • Renin
  • Prazosin